179 related articles for article (PubMed ID: 37724205)
21. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
[TBL] [Abstract][Full Text] [Related]
22. Assessment of left ventricular function in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease using three-dimensional speckle-tracking echocardiography.
Dong Y; Cui H; Sun L; Wang Y; Li Y; Chang W; Li G; Huang D
Anatol J Cardiol; 2020 Jan; 23(1):41-48. PubMed ID: 31911565
[TBL] [Abstract][Full Text] [Related]
23. Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology.
Peng D; Yu Z; Wang M; Shi J; Sun L; Zhang Y; Zhao W; Chen C; Tang J; Wang C; Ni J; Wen W; Jiang J
Front Endocrinol (Lausanne); 2022; 13():935390. PubMed ID: 35928895
[TBL] [Abstract][Full Text] [Related]
24. Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
Kalavalapalli S; Leiva EG; Lomonaco R; Chi X; Shrestha S; Dillard R; Budd J; Romero JP; Li C; Bril F; Samraj G; Pennington J; Townsend P; Orlando F; Shetty S; Mansour L; Silva-Sombra LR; Bedossa P; Malaty J; Barb D; Gurka MJ; Cusi K
J Clin Endocrinol Metab; 2023 Apr; 108(5):1192-1201. PubMed ID: 36378995
[TBL] [Abstract][Full Text] [Related]
25. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction.
Miller A; McNamara J; Hummel SL; Konerman MC; Tincopa MA
Sci Rep; 2020 Jul; 10(1):12440. PubMed ID: 32709942
[TBL] [Abstract][Full Text] [Related]
27. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
28. [Cardiac Structural and Functional Features in Patients With Type 2 Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction:A Study Based on Propensity Score Matching].
Peng KL; Liu YM; Jia XY; Wang H; Gou CL; Xue LL; Zou Q; Zhang WJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):264-272. PubMed ID: 37157074
[TBL] [Abstract][Full Text] [Related]
29. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment.
Goland S; Shimoni S; Zornitzki T; Knobler H; Azoulai O; Lutaty G; Melzer E; Orr A; Caspi A; Malnick S
J Clin Gastroenterol; 2006; 40(10):949-55. PubMed ID: 17063117
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Subclinical Myocardial Changes in Non-Alcoholic Fatty Liver Disease: A Case-Control Study Using Speckle Tracking Echocardiography.
Zamirian M; Samiee E; Moaref A; Abtahi F; Tahamtan M
Iran J Med Sci; 2018 Sep; 43(5):466-472. PubMed ID: 30214098
[TBL] [Abstract][Full Text] [Related]
31. Association Between Subclinical Left Ventricular Myocardial Systolic Dysfunction Detected by Strain and Strain‑Rate Imaging and Liver Steatosis and Fibrosis Detected by Elastography and Controlled Attenuation Parameter in Patients with Metabolic Syndrome.
Vitel A; Sporea I; Mare R; Banciu C; Bordejevic DA; Parvanescu T; Citu IM; Tomescu MC
Diabetes Metab Syndr Obes; 2020; 13():3749-3759. PubMed ID: 33116724
[TBL] [Abstract][Full Text] [Related]
32. Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
Nobarani S; Alaei-Shahmiri F; Aghili R; Malek M; Poustchi H; Lahouti M; Khamseh ME
Dig Dis Sci; 2022 Apr; 67(4):1389-1398. PubMed ID: 33788095
[TBL] [Abstract][Full Text] [Related]
33. Cardiac Structure and Function in Young Adults With Various Cardiometabolic Profiles.
Parve SD; Sineglazova AV
Cureus; 2023 Jun; 15(6):e40524. PubMed ID: 37333045
[TBL] [Abstract][Full Text] [Related]
34. Associations between serum biomarkers and non-alcoholic liver disease: Results of a clinical study of Mediterranean patients with obesity.
De Nucci S; Castellana F; Zupo R; Lampignano L; Di Chito M; Rinaldi R; Giannuzzi V; Cozzolongo R; Piazzolla G; Giannelli G; Sardone R; De Pergola G
Front Nutr; 2022; 9():1002669. PubMed ID: 36159489
[TBL] [Abstract][Full Text] [Related]
35. Echocardiography and NAFLD (non-alcoholic fatty liver disease).
Trovato FM; Martines GF; Catalano D; Musumeci G; Pirri C; Trovato GM
Int J Cardiol; 2016 Oct; 221():275-9. PubMed ID: 27404689
[TBL] [Abstract][Full Text] [Related]
36. Left atrial deformation parameters in patients with non-alcoholic fatty liver disease: a 2D speckle tracking imaging study.
Kocabay G; Karabay CY; Colak Y; Oduncu V; Kalayci A; Akgun T; Guler A; Kirma C
Clin Sci (Lond); 2014 Feb; 126(4):297-304. PubMed ID: 23947743
[TBL] [Abstract][Full Text] [Related]
37. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.
Petta S; Argano C; Colomba D; Cammà C; Di Marco V; Cabibi D; Tuttolomondo A; Marchesini G; Pinto A; Licata G; Craxì A
J Hepatol; 2015 Apr; 62(4):928-33. PubMed ID: 25445395
[TBL] [Abstract][Full Text] [Related]
38. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
39. Triglyceride to high-density lipoprotein cholesterol ratio is an independent predictor of liver fibrosis among pediatrics non-alcoholic fatty liver disease.
Ting YW; Jalaludin MY; Zaini AA; Mohamed R
Front Endocrinol (Lausanne); 2022; 13():1071350. PubMed ID: 36589844
[TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes.
Mantovani A; Pernigo M; Bergamini C; Bonapace S; Lipari P; Pichiri I; Bertolini L; Valbusa F; Barbieri E; Zoppini G; Bonora E; Targher G
PLoS One; 2015; 10(8):e0135329. PubMed ID: 26252899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
